TITAY AYANO: Open Payments
NPI 1487354684 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,989 in 135 payments from 20 companies in 2025. Trend: 2023 $3,060 · 2024 $2,658 · 2025 $3,989
Food & beverage: $3,976Education: $13
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $696 |
| Galderma Laboratories, L.P. | 13 | $436 |
| Novartis Pharmaceuticals Corporation | 17 | $419 |
| Janssen Biotech, Inc. | 18 | $415 |
| ABBVIE INC. | 15 | $388 |
| GENZYME CORPORATION | 7 | $279 |
| Organon LLC | 12 | $264 |
| Regeneron Healthcare Solutions, Inc. | 10 | $264 |
| UCB, Inc. | 8 | $220 |
| Lilly USA, LLC | 3 | $139 |
Products named: ILUMYA, DUPIXENT, TREMFYA, NEMLUVIO, COSENTYX, Bimzelx, SKYRIZI, VTAMA.
Industry payments across TN — which companies pay providers there.
